Brickell Stock Alpha and Beta Analysis


USD 0.10  0.03  23.08%   

This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Brickell Biotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in Brickell Biotech over a specified time horizon. Remember, high Brickell Biotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation.
Continue to Brickell Biotech Backtesting, Brickell Biotech Valuation, Brickell Biotech Correlation, Brickell Biotech Hype Analysis, Brickell Biotech Volatility, Brickell Biotech History and analyze Brickell Biotech Performance.
Please note that although Brickell Biotech alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., DOW index.) So in this particular case, Brickell Biotech did 0.84  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Brickell Biotech stock's relative risk over its benchmark. Brickell Biotech has a beta of 1.30  . Let's try to break down what Brickell's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Brickell Biotech will likely underperform.
Brickell Biotech Tangible Assets Book Value per Share are most likely to decrease significantly in the upcoming years. The last year's value of Tangible Assets Book Value per Share was reported at 0.37. The current Enterprise Value is estimated to increase to about 5.1 M, while Enterprise Value over EBIT is projected to decrease to (1.24) .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.

Brickell Biotech Quarterly Book Value per Share



Brickell Biotech Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Brickell Biotech market risk premium is the additional return an investor will receive from holding Brickell Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Brickell Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Brickell Biotech's performance over market.
α-0.84   β1.30
90 days against DJI

Brickell Biotech expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Brickell Biotech's Buy-and-hold return. Our buy-and-hold chart shows how Brickell Biotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Brickell Biotech Market Price Analysis

Market price analysis indicators help investors to evaluate how Brickell Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Brickell Biotech shares will generate the highest return on investment. By understating and applying Brickell Biotech stock market price indicators, traders can identify Brickell Biotech position entry and exit signals to maximize returns.

Brickell Biotech Return and Market Media

The median price of Brickell Biotech for the period between Sun, Apr 3, 2022 and Sat, Jul 2, 2022 is 0.19 with a coefficient of variation of 33.58. The daily time series for the period is distributed with a sample standard deviation of 0.07, arithmetic mean of 0.2, and mean deviation of 0.06. The Stock received some media coverage during the period.
 Price Growth (%)  
Has Brickell Biotech Outpaced Other Medical Stocks This Year...04/19/2022
Brickell Biotech stock surges postmarket on sale of rights t...05/03/2022
Acquisition by Chadha Deepak of 325000 shares of Brickell Bi...05/09/2022
EPS Reported05/12/2022
Acquisition by Veru Dennison T of 65000 shares of Brickell B...05/17/2022
Financial Statements05/25/2022
Financial Statements06/07/2022
Financial Statements06/15/2022
Brickell Biotech sets special shareholders meeting to avoid ...06/22/2022

About Brickell Biotech Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all equity instruments such as Ford or other stocks, funds, and ETFs. Alpha measures the amount that position in Brickell Biotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2017 2018 2021 2022 (projected)
Accounts Payable Turnover17.962.02.32.36
PPandE Turnover15.544.594.144.69

Brickell Biotech Upcoming Company Events

As portrayed in its financial statements, the presentation of Brickell Biotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brickell Biotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Brickell Biotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Brickell Biotech. Please utilize our Beneish M Score to check the likelihood of Brickell Biotech's management manipulating its earnings.
Upcoming Quarterly Report8th of March 2022
Next Financial Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End8th of March 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Build Portfolio with Brickell Biotech

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Continue to Brickell Biotech Backtesting, Brickell Biotech Valuation, Brickell Biotech Correlation, Brickell Biotech Hype Analysis, Brickell Biotech Volatility, Brickell Biotech History and analyze Brickell Biotech Performance. Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Brickell Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Brickell Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Brickell Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...